ArticleBiotechnology progress2021

Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential.

Haibin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.